Lamberto Re

Prof. Lamberto Re

Molecular Pharmacology, University of Ancona, Ancona, Italy

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2008 in Archives of Medical Research
Verified
Journal Article
Closed access
Lamberto ReLamberto Re
Lamberto Re
MMMohamed N. Mawsouf
Mohamed N. Mawsouf
SMSilvia Menéndez
Silvia Menéndez
OLOlga S. León
Olga S. León
GSGregorio M. Sánchez
Gregorio M. Sánchez
FHFrank Hernández
Frank Hernández

1 November 2014 in European Journal of Pharmacology
Verified
Journal Article
Closed access
Lamberto ReLamberto Re
Lamberto Re
Gregorio Martínez-SánchezGregorio Martínez-Sánchez
Gregorio Martínez-Sánchez
MBMarica Bordicchia
Marica Bordicchia
GMGiuseppe Malcangi
Giuseppe Malcangi
APAntonella Pocognoli
Antonella Pocognoli
ARArmando Rojas
Armando Rojas

1 January 2006 in Pharmacological Research
Verified
Journal Article
Closed access
Lamberto ReLamberto Re
Lamberto Re
FRF Rossini
F Rossini
FRF Re
F Re
MBM Bordicchia
M Bordicchia
AMA Mercanti
A Mercanti
SBS Barocci
S Barocci

1 October 2020 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
ASAhmed M. Shehata
Ahmed M. Shehata
OAOmar Ahmed-Farid
Omar Ahmed-Farid
HRHanan A. Rizk
Hanan A. Rizk
SSSara M. Saber
Sara M. Saber
FLFawzy M. Lashin
Fawzy M. Lashin
Lamberto ReLamberto Re
Lamberto Re
Despite the fact that levodopa has proven its effectiveness in treating the symptoms of Parkinson's disease (PD), increasing concerns have emerged about its possible long-term toxic effects on dopamine (DA) neurons. The study investigated the possible ameliorative effect of virgin coconut oil against l-dopa- induced neurotoxicity in adult rats. A total number of 40 rats were divided into four groups. Briefly, the first served as control, the second was orally administered virgin coconut oil (1.42 mL/kg), the third group was administered a single daily dose of l-dopa/carbidopa (100/10 mg/kg/day, p.o) and the fourth group pre-treated with virgin coconut oil then administered a single daily dose of l-dopa/carbidopa. The different treatments were extended for 30 days. l-dopa treated group exhibited aggressive behavior and behavioral abnormalities in open field test compared to control group. In addition, l-dopa treatment caused significant increase in the levels of striatal dopamine and norepinephrine and their metabolites with concomitant decrease of serotonin and its metabolite. Moreover, l-dopa treatment increased histamine and GABA levels. In addition, l-dopa treatment induced oxidative stress and energy crisis. The histological and immunohistochemical studies showed that l-dopa caused a remarkable neurodegeneration and increased glial fibrillary acidic protein (GFAP) immunoexpression in the striatal area. Virgin coconut oil co-treatment significantly minimized the harmful effects of l-dopa. In conclusion, the present study revealed that virgin coconut oil provided a notable protection against l-dopa's untoward effects.

1 December 2010 in Saudi Medical Journal
Verified
Journal Article
Closed access
Lamberto ReLamberto Re
Lamberto Re
GSGregorio M. Sanchez
Gregorio M. Sanchez
NMNabil Mawsouf
Nabil Mawsouf
OBJECTIVE: To address the clinical evidence that may support the fact that subcutaneous administration of ozone has anti-hyperalgesic effects probably acting by modifying specific pain targets. METHODS: Fifty-two patients attending the Medinat Clinic, Camerano, Ancona, Italy between October 2004 to October 2009 were eligible to participate in the study. Panoramic photos of painful and not painful areas submitted to oxygen /ozone treatment injection were analyzed to detect the intensity of erythema. RESULTS: The erythematic areas after ozone subcutaneous puncture showed significant (p<0.05) increment (83±5%) in the painful area versus 7±6% in the contralateral area. CONCLUSION: The surrounding erythema observed during ozone intervention should explain at least in part, its interaction with some pain mediators. This may involve algesic mediators or receptors. The analgesic mechanism induced by oxygen/ozone may involve 2 independent steps: a short-term mechanism that may correspond with the direct oxidation on biomolecules, and a long-term mechanism that may involve the activation of antioxidant pathways. Further studies are needed to support the biochemical analgesic mechanism of ozone therapy.

23 February 2022 in Frontiers in Physiology
Verified
Journal Article
Open access
Lamberto ReLamberto Re
Lamberto Re
Notwithstanding the use of ozone in medicine has become widespread in many countries of the world, its real pharmacological action remains not completely clarified. We know that other than its uses as disinfectant, well documented by the literature since the beginning of the past century, the more recent medical use of ozone in several pathologies as described by the international literature is still poor investigated. Furthermore, following its clinical uses with excellent clinical responses on several heterogeneous diseases and pain, it is now clear that the biological activity of this gas is mediated by graded responses to the mild oxidative stress induced after its application. Thus, the ancestral environment of our cells, whose energy production is strictly bind to oxygen burn, may be mediated by common defenses probably linked to the ubiquitous signaling pathway mediated by Nrf2. Moreover, after the first description of the oxidative stress in the 1970s and the discovery of Nrf2 as transcription factor in 1994, we could observe a rapid growth of the literatures regarding its function as master regulator of a myriad of cellular processes and its association to a multiple pattern of diseases including aging. In conclusion, to our opinion, the Systems Medicine approach could finally give to us the real key to better understand the wide reported efficacy of ozone treatment.